{
  "slug": "parkinsons-progression-markers-initiative-ppmi",
  "name": "Parkinsons Progression Markers Initiative Ppmi",
  "description": "The Parkinson's Progression Markers Initiative (PPMI) is a comprehensive, international study that collects robust, real-time, open-access data to accelerate breakthroughs in understanding Parkinson's disease. It involves thousands of volunteers, including those with and without Parkinson's, and provides data for researchers globally.",
  "url": "https://optimly.ai/brand/parkinsons-progression-markers-initiative-ppmi",
  "websiteUrl": "https://ppmi-info.org/",
  "logoUrl": "https://logo.clearbit.com/ppmi-info.org",
  "baiScore": 54,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Challenger",
  "archetype_status": "active",
  "category": "Medical Research",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-09T00:02:34.897Z",
  "verifiedVitals": {
    "website": "https://ppmi-info.org",
    "founded": "2010",
    "headquarters": "Not explicitly stated (affiliated with Michael J. Fox Foundation)",
    "pricing_model": "Open access for data (implied non-profit/grant-funded initiative).",
    "core_products": "Longitudinal clinical, imaging, and biological data from Parkinson's patients and controls; an open-access data portal; research publications and presentations.",
    "key_differentiator": "Its large-scale, international, longitudinal design, comprehensive data collection across diverse cohorts (including prodromal), and a commitment to real-time, open-access data sharing to accelerate research breakthroughs.",
    "target_markets": "Parkinson's researchers, pharmaceutical companies, academic institutions, clinicians, individuals with Parkinson's disease or risk factors, and the wider scientific community.",
    "employee_count": "Not specified",
    "funding_stage": "Ongoing, likely multi-year grant-funded initiative",
    "subcategory": "Parkinson's Disease Research"
  },
  "intentTags": {
    "problemIntents": [
      "Individual Lab-Specific Studies: Researchers conducting smaller-scale, often siloed studies on Parkinson's progression markers, with limited standardization and data sharing across institutions.",
      "Contract Research Organizations (CROs) for Clinical Trials: CROs manage drug trials, which collect data, but typically for specific therapeutic interventions rather than broad, open-access biomarker d",
      "Fragmented Research: Without a coordinating effort like PPMI, research into Parkinson's progression markers would likely remain less integrated, slower, and potentially redundant, hindering the pace o"
    ],
    "solutionIntents": [
      "Parkinson's progression markers initiative",
      "PPMI data access",
      "volunteer Parkinson's study",
      "Electronic Health Record (EHR) Data Analysis: Utilizing de-identified patient data from EHR systems. While large, EHR data may lack the depth, standardization, and specific research-focused assessment"
    ],
    "evaluationIntents": []
  },
  "businessProfileClaims": [],
  "timestamp": 1786557101403
}